IO Biotech Inc (IOBT)
0.8538
-0.12
(-11.98%)
USD |
NASDAQ |
Nov 14, 16:00
0.88
+0.03
(+3.07%)
After-Hours: 20:00
IO Biotech Enterprise Value: -36.84M for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | -36.84M |
| November 12, 2024 | -39.65M |
| November 11, 2024 | -31.57M |
| November 08, 2024 | -28.28M |
| November 07, 2024 | -19.71M |
| November 06, 2024 | -24.33M |
| November 05, 2024 | -24.98M |
| November 04, 2024 | -23.01M |
| November 01, 2024 | -21.69M |
| October 31, 2024 | -19.05M |
| October 30, 2024 | -16.42M |
| October 29, 2024 | -15.43M |
| October 28, 2024 | -13.13M |
| October 25, 2024 | -21.03M |
| October 24, 2024 | -20.37M |
| October 23, 2024 | -19.05M |
| October 22, 2024 | -19.71M |
| October 21, 2024 | -22.35M |
| October 18, 2024 | -19.05M |
| October 17, 2024 | -21.03M |
| October 16, 2024 | -22.35M |
| October 15, 2024 | -22.35M |
| October 14, 2024 | -24.33M |
| October 11, 2024 | -29.60M |
| October 10, 2024 | -32.89M |
| Date | Value |
|---|---|
| October 09, 2024 | -28.28M |
| October 08, 2024 | -24.98M |
| October 07, 2024 | -30.25M |
| October 04, 2024 | -24.98M |
| October 03, 2024 | -34.21M |
| October 02, 2024 | -31.57M |
| October 01, 2024 | -31.58M |
| September 30, 2024 | -31.57M |
| September 27, 2024 | -30.91M |
| September 26, 2024 | -30.25M |
| September 25, 2024 | -31.57M |
| September 24, 2024 | -32.23M |
| September 23, 2024 | -26.96M |
| September 20, 2024 | -26.30M |
| September 19, 2024 | -22.35M |
| September 18, 2024 | -24.33M |
| September 17, 2024 | -22.35M |
| September 16, 2024 | -49.68M |
| September 13, 2024 | -51.27M |
| September 12, 2024 | -50.16M |
| September 11, 2024 | -47.05M |
| September 10, 2024 | -42.11M |
| September 09, 2024 | -41.58M |
| September 06, 2024 | -45.14M |
| September 05, 2024 | -41.78M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-109.83M
Minimum
Oct 27 2023
451.68M
Maximum
Nov 05 2021
-27.35M
Average
-41.63M
Median
Enterprise Value Benchmarks
| Merck & Co Inc | 272.77B |
| NovaBay Pharmaceuticals Inc | 3.432M |
| Palatin Technologies Inc | 13.74M |
| iBio Inc | 6.814M |
| Theriva Biologics Inc | -13.26M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -20.69M |
| Total Expenses (Quarterly) | 21.53M |
| EPS Diluted (Quarterly) | -0.31 |
| Earnings Yield | -168.4% |